United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
Stock Snapshot
As of today, United Therapeutics(UTHR) shares are valued at $529.34. The company's market cap stands at 22.45B, with a P/E ratio of 19.53.
On 2026-07-21, United Therapeutics(UTHR) shares started trading at $535.43, with intraday highs of — and lows of —.
Trading volume for United Therapeutics(UTHR) stock has reached 0, versus its average volume of 364.02K.
The stock's 52-week range extends from a low of $272.12 to a high of $609.35.
The stock's 52-week range extends from a low of $272.12 to a high of $609.35.
UTHR News
...
Analyst ratings
81%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.